𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Diversification and progression of malignant tumors

✍ Scribed by Garth L. Nicolson; Nancy L. Rosenberg


Book ID
102760322
Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
641 KB
Volume
6
Category
Article
ISSN
0265-9247

No coin nor oath required. For personal study only.

✦ Synopsis


Tumor-cell diversification mechanisms insure that malignant neoplasms contain diversijied tumor-cell subpopulations. Because of the instability of tumor cell phenotypes, some malignant cells will evolve with the most favorable properties for their progression to highly metastatic cells. The rates of cellular phenotypic diversijication vary greatly among different tumors, and they are probably modulated, in part, by genetic and chromosome defects and by epigenetic events that may vary widely depending upon the nature of the tumor cells and their microenvironments. As tumor diversijication and selection proceed, the most malignant cell subpopulations may eventually become dominant and gradually lose their microenvironmental responsiveness. Tumor-cell diversijication mechanisms may be similar or identical to normal, developmentally regulated diversijication mechanisms that are used during embryonic cell diversijication and differen tiat ion.


πŸ“œ SIMILAR VOLUMES


Tumor recurrence and malignant progressi
✍ Michael Majores; Marec von Lehe; Jana Fassunke; Johannes Schramm; Albert J. Beck πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 460 KB

## Abstract ## BACKGROUND. Most gangliogliomas (GGs) are benign tumors, but tumor recurrence and malignant progression are observed in some patients. ## METHODS. The authors analyzed their experience with 4 recurrent/progressive GGs (World Health Organization [WHO] grade I), 21 tumors with atypi

Gene expression, cellular diversificatio
✍ Garth L. Nicolson πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 754 KB

## Abstract Alterations in the expression of certain genes or in their products can render benign tumor cells metastatic. Experimentally this has been quickly performed by transferring dominantly acting oncogenes such as c‐H‐ras^EJ^ into susceptible cells, but __in vivo__ such a rapid qualitative c